Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 ,inter alia, to consider and approve Increase in Authorized Capital ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samsrita Labs Ltd has informed BSE that its Board of Directors will meet on Wednesday, 30 April 2025, at its registered office in Hyderabad to consider several key matters. The Board will consider increasing the Authorised Capital of the company along with corresponding amendments to the Memorandum of Association. It will also evaluate raising funds by issuing equity shares, convertible warrants, or other securities to promoters or non-promoters on a preferential basis. Another item on the agenda is acquiring a stake in another company through a preferential allotment of equity shares or other securities. Additionally, the Board will discuss amending the Object Clause of the Memorandum of Association. The trading window for designated persons and their relatives remains closed until 30 May 2025.
Existing shareholders may see dilution if the preferential allotments go through, as new shares or convertible securities will likely be issued to promoters or other parties. The proposed acquisition and capital expansion suggest the company is positioning for growth or strategic expansion, but the exact impact on share price will depend on the terms eventually approved.